Aspartame decreases evoked extracellular dopamine levels in the rat brain: An in vivo voltammetry study

Neuropharmacology

Volumn 53, Issue 8, 2007, Pages 967-974

  Bergstrom, Brian P ^a   Cummings, Deirdre R ^a   Skaggs, Tricia A ^a  

^a MUSKINGUM COLLEGE   (United States)

Author keywords

Aspartame; Dopamine; Release; Striatum; Uptake; Voltammetry

Indexed keywords

ASPARTAME; DOPAMINE; OXIDOPAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIET; DOPAMINE BLOOD LEVEL; EVOKED RESPONSE; FOOD INTAKE; IN VIVO STUDY; KINETICS; NONHUMAN; POTENTIOMETRY; PRIORITY JOURNAL; RAT; STIMULUS RESPONSE;

ANALYSIS OF VARIANCE; ANIMALS; ASPARTAME; BRAIN INJURIES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CORPUS STRIATUM; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, RADIATION; ELECTRIC STIMULATION; ELECTROCHEMISTRY; EXTRACELLULAR FLUID; MALE; OXIDOPAMINE; RATS; RATS, SPRAGUE-DAWLEY; SWEETENING AGENTS; TIME FACTORS;

EID: 36248935631     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2007.09.009     Document Type: Article

References (51)

1. Altar C.A., Marien M.R., and Marshall J.F. Time course of adaptations in dopamine biosynthesis, metabolism, and release following nigrostriatal lesions: implications for behavioral recovery from brain injury. J. Neurochem. 48 (1987) 390-399
2. Aragon M.C., Gimenez C., and Valdivieso F. Inhibition by l-phenylalanine of tyrosine transport by synaptosomal plasma membrane vesicles: implications in the pathogenesis of phenylketonuria. J. Neurochem. 39 (1982) 1185-1187
3. Bergstrom B.P., Schertz K.E., Weirick T., Nafziger B., Takacs S.A., Lopes K.O., Massa K.J., Walker Q.D., and Garris P.A. Partial, graded losses of dopamine terminals in the rat caudate-putamen: an animal model for the study of compensatory adaptation in preclinical parkinsonism. J. Neurosci. Methods 106 (2001) 15-28
4. Burgert S.L., Anderson D.W., Stegink L.D., Takeuchi H., and Schedl H.P. Metabolism of aspartame and its l-phenylalanine methyl ester decomposition product by the porcine gut. Metabolism 40 (1991) 612-618
5. Cahill P.S., Walker Q.D., Finnegan J.M., Mickelson G.E., Travis E.R., and Wightman R.M. Microelectrodes for the measurement of catecholamines in biological systems. Anal. Chem. 68 (1996) 3180-3186
6. Cooper J.R., Bloom F.E., and Roth R.H. The Biochemical Basis of Neuropharmacology (2003), University Press, Oxford
7. Coulombe Jr. R.A., and Sharma R.P. Neurobiochemical alterations induced by the artificial sweetener aspartame (nutrasweet). Toxicol. Appl. Pharmacol. 83 (1986) 79-85
8. Fallon J.H., and Moore R.Y. Catecholamine innervation of the basal forebrain. IV. Topography of the dopamine projection to the basal forebrain and neostriatum. J. Comp. Neurol. 180 (1978) 545-580
9. FDA. Food additives permitted for direct addition to food for human consumption. Fed. Regist. 49 (1984) 6672-6682
10. Fernstrom J.D., Fernstrom M.H., and Gillis M.A. Acute effects of aspartame on large neutral amino acids and monoamines in rat brain. Life Sciences 32 (1983) 1651-1658
11. Fernstrom J.D. Oral aspartame and plasma phenylalanine: pharmacokinetic difference between rodents and man, and relevance to CNS effects of phenylalanine. J. Neural Transm. 75 (1989) 159-164
12. Freeman G., Sobotka T., and Hattan D. Acute effects of aspartame on concentrations of brain amines and their metabolites in selected brain regions of fischer 344 and sprague-dawley rats. Drug Chem. Toxicol. 13 (1990) 113-133
13. Garris P.A., Ciolkowski E.L., and Wightman R.M. Heterogeneity of evoked dopamine overflow within the striatal and striatoamygdaloid regions. Neuroscience 59 (1994) 417-427
14. Garris P.A., and Rebec G.V. Modeling fast dopamine neurotransmission in the nucleus accumbens during behavior. Behav. Brain Res. 137 (2002) 47-63
15. Garris P.A., and Wightman R.M. Different kinetics govern dopaminergic transmission in the amygdala, prefrontal cortex, and striatum: an in vivo voltammetric study. J. Neurosci. 14 (1994) 442-450
16. Gerfen C.R., Herkenham M., and Thibault J. The neostriatal mosaic: II. Patch- and matrix-directed mesostriatal dopaminergic and non-dopaminergic systems. J. Neurosci. 7 (1987) 3915-3934
17. Goerss A.L., Wagner G.C., and Hill W.L. Acute effects of aspartame on aggression and neurochemistry of rats. Life Sci. 67 (2000) 1325-1329
18. Grace A.A. The tonic/phasic model of dopamine system regulation and its implications for understanding alcohol and psychostimulant craving. Addiction 95 suppl. 2 (2000) S119-S128
19. Hefti F., Enz A., and Melamed E. Partial lesions of the nigrostriatal pathway in the rat. Acceleration of transmitter synthesis and release of surviving dopaminergic neurones by drugs. Neuropharmacology 24 (1985) 19-23
20. Herdon H., Strupish J., and Nahorski S.R. Differences between the release of radiolabelled and endogenous dopamine from superfused rat brain slices: effects of depolarizing stimuli, amphetamine and synthesis inhibition. Brain Res. 348 (1985) 309-320
21. Hjelle J.J., Dudley R.E., Marietta M.P., Sanders P.G., Dickie B.C., Brisson J., and Kotsonis F.N. Plasma concentrations and pharmacokinetics of phenylalanine in rats and mice administered aspartame. Pharmacology 44 (1992) 48-60
22. Ikeda M., Levitt M., and Udenfriend S. Phenylalanine as substrate and inhibitor of tyrosine hydroxylase. Arch. Biochem. Biophys. 120 (1967) 420-427
23. Karstaedt P.J., and Pincus J.H. Aspartame use in Parkinson's disease. Neurology 43 (1993) 611-613
24. Kawagoe K.T., Garris P.A., Wiedemann D.J., and Wightman R.M. Regulation of transient dopamine concentration gradients in the microenvironment surrounding nerve terminals in the rat striatum. Neuroscience 51 (1992) 55-64
25. Kiritsy P.J., and Maher T.J. Acute effects of aspartame on systolic blood pressure in spontaneously hypertensive rats. J. Neural Transm. 66 (1986) 121-128
26. Koeppe R.A., Shulkin B.L., Rosenspire K.C., Shaw L.A., Betz A.L., Mangner T., Price J.C., and Agranoff B.W. Effect of aspartame-derived phenylalanine on neutral amino acid uptake in human brain: a positron emission tomography study. J. Neurochem. 56 (1991) 1526-1535
27. Kuhr W.G., Bigelow J.C., and Wightman R.M. In vivo comparison of the regulation of releasable dopamine in the caudate nucleus and the nucleus accumbens of the rat brain. J. Neurosci. 6 (1986) 974-982
28. Mackey S.A., and Berlin C.M. Effect of dietary aspartame on plasma concentrations of phenylalanine and tyrosine in normal and homozygous phenylketonuric patients. Clin. Pediatr. 31 7 (1992) 394-399
29. Matthews D.M. Absorption of peptides, amino acids and their methylated derivatives. In: Stegink L.D., and Filer Jr. L.J. (Eds). Aspartame: Physiology and Biochemistry (1984), Marcel Dekker, New York 29-46
30. Maher T.J., and Wurtman R.J. Possible neurologic effects of aspartame, a widely used food additive. Environ. Health Perspect. 75 (1987) 53-57
31. McMillen B.A., German D.C., and Shore P.A. Functional and pharmacological significance of brain dopamine and norepinephrine storage pools. Biochem. Pharmacol. 29 (1980) 3045-3050
32. Michael D., Travis E.R., and Wightman R.M. Color images for fast-scan CV measurements in biological systems. Anal. Chem. 70 (1998) 586A-592A
33. Michael D.J., Joseph J.D., Kilpatrick M.R., Travis E.R., and Wightman R.M. Improving data acquisition for fast-scan cyclic voltammetry. Anal. Chem. 71 (1999) 3941-3947
34. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates (1986), Academic Press, New York
35. Perego C., De Simoni M.G., Fodritto F., Raimondi L., Diomede L., Salmona M., Algeri S., and Garattini S. Toxicol. Lett. 44 (1988) 331-339
36. Phillips P.E., Stuber G.D., Heien M.L., Wightman R.M., and Carelli R.M. Subsecond dopamine release promotes cocaine seeking. Nature 422 (2003) 614-618
37. Robinson D.L., Phillips P.E., Budygin E.A., Trafton B.J., Garris P.A., and Wightman R.M. Sub-second changes in accumbal dopamine during sexual behavior in male rats. Neuroreport 12 (2001) 2549-2552
38. Romano M., Diomede L., Guiso G., Caccia S., Perego C., and Salmona M. Plasma and brain kinetics of large neutral amino acids and of striatum monoamines in rats given aspartame. Food Chem. Toxicol. 28 (1990) 317-321
39. Schultz W. Predictive reward signal of dopamine neurons. J. Neurophysiol. 80 (1998) 1-27
40. Sharma R.P., and Coulombe Jr. R.A. Effects of repeated doses of aspartame on serotonin and its metabolite in various regions of the mouse brain. Food Chem. Toxicol. 25 (1987) 565-568
41. Smith Q.R., Momma S., Aoyagi M., and Rapoport S.I. Kinetics of neutral amino acid transport across the blood brain barrier. J. Neurochem. 49 (1987) 1651-1658
42. Torii K., Mimura T., Takasaki Y., and Ichimura M. Dietary aspartame with protein on plasma and brain amino acids, brain monoamine and behavior in rats. Physiol. Behav. 36 (1986) 765-771
43. Venton B.J., Zhang H., Garris P.A., Phillips P.E.M., Sulzer D., and Wightman R.M. Real-time decoding of dopamine concentration changes in the caudate-putamen during tonic and phasic firing. J. Neurochem. 87 (2003) 1284-1295
44. Wightman R.M., Amatore C., Engstrom R.C., Hale P.D., Kristensen E.W., Kuhr W.G., and May L.J. Real-time characterization of dopamine overflow and uptake in the rat striatum. Neuroscience 25 (1988) 513-523
45. Wolf M.E., Zigmond M.J., and Kapatos G. Tyrosine hydroxylase content of residual striatal dopamine nerve terminals following 6-hydroxydopamine administration: a flow cytometric study. J. Neurochem. 53 (1989) 879-885
46. Wu Q., Reith M.E., Kuhar M.J., Carroll F.I., and Garris P.A. Preferential increases in nucleus accumbens dopamine after systemic cocaine administration are caused by unique characteristics of dopamine neurotransmission. J. Neurosci. 21 (2001) 6338-6347
47. Wu Q., Reith M.E., Wightman R.M., Kawagoe K.T., and Garris P.A. Determination of release and uptake parameters from electrically evoked dopamine dynamics measured by real-time voltammetry. J. Neurosci. Methods 112 (2001) 119-133
48. Wurtman R.J. Neurochemical changes following high-dose aspartame with dietary carbohydrates. N. Engl. J. Med. 309 (1983) 429-430
49. Wurtman R.J., and Maher T.J. Effects of oral aspartame on plasma phenylalanine in humans and experimental rodents. J. Neural Transm. 70 (1987) 169-173
50. Yokogoshi H., and Wurtman R.J. Acute effects of oral or parenteral aspartame on catecholamine metabolism in various regions of rat brain. J. Nutr. 116 (1986) 356-364
51. Zigmond M.J., Acheson A.L., Stachowiak M.K., and Stricker E.M. Neurochemical compensation after nigrostriatal bundle injury in an animal model of preclinical parkinsonism. Arch. Neurol. 41 (1984) 856-861